[Skip to Content]
[Skip to Content Landing]
Views 205
Citations 0
Invited Commentary
October 2018

Is Venous Thromboembolism in Asian Patients Undergoing Gastrectomy Different From Venous Thromboembolism in Their Western Counterparts?

Author Affiliations
  • 1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 2Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 3Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 4Department of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 5The Armstrong Institute for Patient Safety and Quality, Johns Hopkins Medicine, Baltimore, Maryland
  • 6Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
JAMA Surg. 2018;153(10):946-947. doi:10.1001/jamasurg.2018.2082

In this issue of JAMA Surgery, Jung and colleagues1 examine the safety and efficacy of venous thromboembolism (VTE) prophylaxis in Korean patients undergoing gastrectomy for cancer. Their randomized clinical trial found decreased postoperative VTE with the use of low-molecular-weight heparin in addition to mechanical prophylaxis, compared with the use of mechanical prophylaxis alone. However, the authors claim that, because the VTE rate was low and the rate of bleeding was increased, VTE prophylaxis (low-molecular-weight heparin plus intermittent pneumatic compression) still may not be the right choice for all patients undergoing gastrectomy. Although we were pleased to see this focus on VTE, which until recently was understudied in Asian patients,2 we do have some questions about this trial and its conclusions.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×